{"address1": "77 4th Avenue", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "(781) 663-6900", "website": "https://www.revvity.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company's Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in oncology, screening newborns for rare genetic conditions, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BioQule, BoBs, chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPatternTM, Evolution Evoya, explorer, Fontus, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Omni Bead Ruptor, Omni Bead Ruptor Elite, Omni Tip, Pannoramic, Panthera Puncher, PG-Seq, PG-Find, PreNAT II, Prime, Protein Clear, ProteinEXact, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord, VICTOR2D, and Zephyr brands. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 11000, "companyOfficers": [{"maxAge": 1, "name": "Dr. Prahlad R. Singh Ph.D.", "age": 59, "title": "CEO, President & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 3685279, "exercisedValue": 2237008, "unexercisedValue": 1265897}, {"maxAge": 1, "name": "Mr. Maxwell  Krakowiak", "age": 34, "title": "Senior VP & CFO", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 1147898, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tajinder S. Vohra", "age": 58, "title": "Senior Vice President of Global Operations", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1004500, "exercisedValue": 402379, "unexercisedValue": 398339}, {"maxAge": 1, "name": "Mr. Joel S. Goldberg", "age": 55, "title": "Senior VP of Administration, General Counsel & Secretary", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1321274, "exercisedValue": 1163793, "unexercisedValue": 930863}, {"maxAge": 1, "name": "Ms. Miriame  Victor", "age": 42, "title": "Senior VP & Chief Commercial Officer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 1024157, "exercisedValue": 0, "unexercisedValue": 146225}, {"maxAge": 1, "name": "Mr. Bryan A. Kipp", "title": "Senior VP of Technology & Licensing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Madhuri  Hegde FACMG, Ph.D.", "title": "Senior VP & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen Barr Willoughby", "title": "Senior VP of Investor Relations & Head of ESG", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Magali  Four", "title": "Senior VP and Chief People & Culture Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Francis Friel", "age": 68, "title": "Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 6898326, "exercisedValue": 0, "unexercisedValue": 29870628}], "auditRisk": 9, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.perkinelmer.com/OurCompany/Investors/default.xhtml", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 105.8, "open": 105.33, "dayLow": 103.77, "dayHigh": 106.93, "regularMarketPreviousClose": 105.8, "regularMarketOpen": 105.33, "regularMarketDayLow": 103.77, "regularMarketDayHigh": 106.93, "dividendRate": 0.28, "dividendYield": 0.27, "exDividendDate": 1744848000, "payoutRatio": 0.121700004, "fiveYearAvgDividendYield": 0.22, "beta": 1.066, "trailingPE": 45.550217, "forwardPE": 20.215117, "volume": 980274, "regularMarketVolume": 980274, "averageVolume": 963253, "averageVolume10days": 959400, "averageDailyVolume10Day": 959400, "bid": 0.0, "ask": 125.0, "bidSize": 14, "askSize": 8, "marketCap": 12532533248, "fiftyTwoWeekLow": 97.32, "fiftyTwoWeekHigh": 129.5, "priceToSalesTrailing12Months": 4.548971, "fiftyDayAverage": 114.7424, "twoHundredDayAverage": 116.2364, "trailingAnnualDividendRate": 0.28, "trailingAnnualDividendYield": 0.0026465028, "currency": "USD", "tradeable": false, "enterpriseValue": 14699145216, "profitMargins": 0.09814, "floatShares": 119570725, "sharesOutstanding": 120147000, "sharesShort": 5179754, "sharesShortPriorMonth": 4484943, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0431, "heldPercentInsiders": 0.0032499998, "heldPercentInstitutions": 0.94975, "shortRatio": 5.1, "shortPercentOfFloat": 0.061100002, "impliedSharesOutstanding": 121501000, "bookValue": 63.549, "priceToBook": 1.6414106, "lastFiscalYearEnd": 1735430400, "nextFiscalYearEnd": 1766966400, "mostRecentQuarter": 1735430400, "earningsQuarterlyGrowth": 0.205, "netIncomeToCommon": 283071008, "trailingEps": 2.29, "forwardEps": 5.16, "lastSplitFactor": "2:1", "lastSplitDate": 991612800, "enterpriseToRevenue": 5.335, "enterpriseToEbitda": 17.548, "52WeekChange": 0.019150019, "SandP52WeekChange": 0.08089435, "lastDividendValue": 0.07, "lastDividendDate": 1737072000, "quoteType": "EQUITY", "currentPrice": 104.31, "targetHighPrice": 162.0, "targetLowPrice": 120.0, "targetMeanPrice": 141.10222, "targetMedianPrice": 140.5, "recommendationMean": 1.9, "recommendationKey": "buy", "numberOfAnalystOpinions": 18, "totalCash": 1163395968, "totalCashPerShare": 9.68, "ebitda": 837635008, "totalDebt": 3325805056, "quickRatio": 2.75, "currentRatio": 3.598, "totalRevenue": 2755025920, "debtToEquity": 43.379, "revenuePerShare": 22.443, "returnOnAssets": 0.01973, "returnOnEquity": 0.036429998, "grossProfits": 1537659008, "freeCashflow": 726416512, "operatingCashflow": 628299008, "earningsGrowth": 0.219, "revenueGrowth": 0.048, "grossMargins": 0.55813, "ebitdaMargins": 0.30403998, "operatingMargins": 0.1871, "financialCurrency": "USD", "symbol": "RVTY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 99153000000, "preMarketChange": -0.29999542, "preMarketChangePercent": -0.28759986, "preMarketPrice": 104.01, "marketState": "PRE", "regularMarketChangePercent": -1.40832, "regularMarketPrice": 104.31, "shortName": "Revvity, Inc.", "longName": "Revvity, Inc.", "regularMarketChange": -1.49001, "regularMarketDayRange": "103.77 - 106.93", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 963253, "fiftyTwoWeekLowChange": 6.989998, "fiftyTwoWeekLowChangePercent": 0.071824886, "fiftyTwoWeekRange": "97.32 - 129.5", "fiftyTwoWeekHighChange": -25.190002, "fiftyTwoWeekHighChangePercent": -0.19451739, "fiftyTwoWeekChangePercent": 1.9150019, "dividendDate": 1746748800, "earningsTimestamp": 1738321200, "earningsTimestampStart": 1745843400, "earningsTimestampEnd": 1746189000, "earningsCallTimestampStart": 1738328400, "earningsCallTimestampEnd": 1738328400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 2.29, "epsForward": 5.16, "epsCurrentYear": 4.95096, "priceEpsCurrentYear": 21.06864, "fiftyDayAverageChange": -10.432404, "fiftyDayAverageChangePercent": -0.09092021, "twoHundredDayAverageChange": -11.926399, "twoHundredDayAverageChangePercent": -0.10260469, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "corporateActions": [{"header": "Dividend", "message": "RVTY announced a cash dividend of 0.07 with an ex-date of Apr. 17, 2025", "meta": {"eventType": "DIVIDEND", "dateEpochMs": 1744862400000, "amount": "0.07"}}], "preMarketTime": 1743598838, "regularMarketTime": 1743537602, "exchange": "NYQ", "messageBoardId": "finmb_268363", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Revvity", "trailingPegRatio": 0.7394}